Sarcoidosis can involve the kidneys directly through granulomatous inflammation, leading to sarcoidosis nephropathy. Although renal failure is an uncommon manifestation, it requires a structured treatment approach when present — particularly when the mechanism is interstitial nephritis or glomerular disease.
This protocol applies to patients with renal insufficiency attributable to sarcoidosis nephropathy, whether the underlying pathology is interstitial nephritis or glomerular disease. The critical goal is to identify and address reversible renal impairment before irreversible loss of function occurs.
When renal insufficiency is documented in this setting, a corticosteroid-based regimen is the established first-line intervention. The protocol defines the starting strategy and a structured tapering course — full details, including the wean schedule, are contained in the complete protocol.
Sarcoidosis nephropathy manifests as interstitial nephritis more commonly than glomerular disease, although renal failure from either mechanism is uncommon.
While there is limited data upon which to base therapeutic recommendations, corticosteroids are usually used with evidence of renal insufficiency starting at 40 mg daily, with a slow wean of therapy as used for other organ involvement.
Usually there is evidence of improvement in renal function with treatment, although normalization of creatinine may not occur.
View source ↗